Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross‐Sectional Study
Health Science Reports · 2026-10 · 9 (10)
DOI: 10.1002/hsr2.73271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 23.09.2026. Verfasst von Younes Sadeghi-Bojd und 4 weiteren Autor:innen. Beteiligte Einrichtung: High Institute for Research and Education in Transfusion Medicine Iranian Blood Transfusion Organization Tehran Iran. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aim The serologic prevalence of the Weak D phenotype varies across populations and may be influenced by laboratory methodology. However, nationwide data from Iran remain limited. This study aimed to determine the nationwide serologic prevalence of the Weak D phenotype among Iranian blood donors and to compare detection rates between manual and automated RhD typing methods.
Methods
This nationwide retrospective cross‐sectional study included 1,991,758 blood donors from all 31 provinces of Iran between December 2022 and December 2023. RhD typing was performed using either manual tube testing or automated platforms (Magnet and solid‐phase red cell adherence [SPRCA]). Prevalence estimates with 95% confidence intervals (CIs) were calculated and compared using χ 2 and paired analyses.
Results
Among 1,991,758 blood donors, 213,693 (10.72%) were Rh‐negative. Serologic Weak D was identified in 1001 donors, corresponding to an overall prevalence of 0.0503% (95% CI: 0.0472–0.0535) and 0.4684% among Rh‐negative donors. The prevalence was 0.0491% with manual testing and 0.0518% with automated testing, with no significant difference between the two methods ( χ 2 = 0.681, p = 0.41). Within the automated group, SPRCA demonstrated a significantly higher detection rate than the Magnet platform (0.0619% [95% CI: 0.0545–0.0707] vs. 0.0445% [95% CI: 0.0390–0.0507]; χ 2 = 12.227, p < 0.001). In provinces where both methods were used concurrently, paired analysis showed a significantly higher mean detection rate with automated testing ( p = 0.023).
Conclusion
The nationwide prevalence of serologically detected Weak D phenotype in Iranian blood donors was 0.0503%, placing Iran within the lower range of global estimates. Although no significant overall difference was observed between manual and automated RhD typing, the Solid Phase platform demonstrated significantly higher detection rates than the Magnet platform. These findings support standardized RhD typing strategies to improve diagnostic consistency and optimize transfusion safety at the national level.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- High Institute for Research and Education in Transfusion Medicine Iranian Blood Transfusion Organization Tehran Iran.
ORCID-Profile: Younes Sadeghi-Bojd, Fatemeh Mohammadali, Arezoo Oodi
Zitieren
APA
Sadeghi-Bojd, Y., Alhosayni, N. S. R., Mirzaeyan, F., Mohammadali, F., & Oodi, A. (2026). Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross‐Sectional Study. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73271
Vancouver
Sadeghi-Bojd Y, Alhosayni NSR, Mirzaeyan F, Mohammadali F, Oodi A. Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross‐Sectional Study. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73271
BibTeX
@article{SadeghiBojd2026,
author = {Sadeghi-Bojd, Younes and Alhosayni, Narges Sadat Razavi and Mirzaeyan, Fatemeh and Mohammadali, Fatemeh and Oodi, Arezoo},
title = {Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/hsr2.73271}
}
EUVIMED